MNST vs TMO Stock Comparison: Price, Growth & Valuation (2026)
Use MEXC Stock Compare for a detailed MNST vs TMO analysis. Compare MNST and TMO across price performance, growth, valuation, profitability and risk, based on market data and the latest reported financials.
MNST vs TMO Stock Comparison Summary
MNST reported year-over-year revenue growth of 20.4%, compared with 7.2% for TMO. Their P/E ratios are 39.7x and 35.8x, dividend yields are 0.00% and 0.27%, and 30-day volatility levels are 24.5% and 24.4%, respectively. These metrics highlight key differences in growth, valuation, dividend income and market risk. Overall TMO leads across more of the selected comparison metrics.
Risk Disclaimer: MEXC Stock Compare provides information and comparisons on actual U.S.-listed stocks for reference only. Data may be delayed or inaccurate, does not constitute investment advice, and past performance does not guarantee future results.
MNST vs TMO Stock Return Comparison (1W)
Compare the cumulative total returns of Monster Beverage Corporation (MNST) and Thermo Fisher Scientific, Inc. (TMO) over the selected 1W period. Data as of 2026-09-25 12:00:00.
MNST vs TMO Key Equity Metrics Comparison Summary
Monster Beverage Corporation (MNST) has a market capitalization of $42.22B and operates in the Consumer Staples sector, with its main business classified under Soft Drinks & Non-alcoholic Beverages. Its latest quarterly revenue changed +20.4% year over year.
Thermo Fisher Scientific, Inc. (TMO) has a market capitalization of $249.48B and operates in the Health Care sector, with its main business classified under Life Sciences Tools & Services. Its latest quarterly revenue changed +7.2% year over year.
MNST vs TMO Key Stock Indicators
| Comparison Metric | MNST | TMO | Comparison results |
Stock Price & Returns Latest delayed stock price with 1-day, 1-month and year-to-date returns. | $43.101D: +1.0%1M: -6.1%1Y: +28.8% | $674.731D: -0.5%1M: +9.3%1Y: +46.1% | TMOWin |
Market Capitalization Total market value of the company's outstanding shares. | $42.22B | $249.48B | TMOWin |
Sector & Industry The company's market sector and primary industry classification. | Consumer Staples / Soft Drinks & Non-alcoholic Beverages | Health Care / Life Sciences Tools & Services | -- |
| Based on delayed market data, MNST is trading at $43.10, compared with $674.73 for TMO. Their market capitalizations are $42.22B and $249.48B, respectively. MNST operates in the Consumer Staples sector, while TMO belongs to Health Care. | |||
| MNST vs TMO Growth & Profitability | |||
Revenue Growth (YoY) Year-over-year change in revenue. | +20.4% | +7.2% | MNSTWin |
EPS Growth (YoY) Year-over-year change in earnings per share. | +33.3% | +7.4% | MNSTWin |
ROIC Return generated from invested capital. | 34.4% | 7.8% | MNSTWin |
Gross Margin / Operating Margin Profitability before and after operating expenses. | 55.5% / 29.2% | 40.8% / 17.6% | MNSTWin |
| On growth, MNST posted revenue growth of +20.4% and TTM EPS growth of +33.3%. TMO, by comparison, posted revenue growth of +7.2% and TTM EPS growth of +7.4%.On profitability, MNST recorded a gross margin of 55.5%, an operating margin of 29.2%, and ROIC of 34.4%. For TMO, the corresponding figures were 40.8%, 17.6%, and 7.8%.Overall, MNST shows stronger overall growth and profitability. | |||
| MNST vs TMO Valuation & Balance Sheet | |||
Free Cash Flow Yield Free cash flow as a percentage of market capitalization. | 2.5% | 2.9% | TMOWin |
Net Debt / EBITDA Net debt relative to EBITDA; a negative value indicates net cash. | -0.7x | 2.6x | MNSTWin |
Dividend Yield / Payout Ratio Dividend returns relative to share price and the share of earnings paid as dividends. | 0.00% / 0.0% | 0.27% / 9.7% | TMOWin |
| TMO offers a higher free cash flow yield, indicating a less demanding valuation. MNST has the stronger balance sheet, while TMO provides the higher dividend yield. Overall, the two stocks differ mainly in valuation, financial strength and dividend income. | |||
| MNST vs TMO Returns & Risk | |||
Total Return (Dividend-Adjusted) Cumulative return over 1, 5 and 10 years, including dividends. | 1Y: +28.8%5Y: +87.9%10Y: +250.1% | 1Y: +46.1%5Y: +13.5%10Y: +324.8% | TMOWin |
30-Day Realized Volatility Annualized volatility based on the past 30 days of daily returns. | 24.5% | 24.4% | TMOWin |
Beta (5Y vs S&P 500) Sensitivity to market movements; above 1 indicates greater market volatility. | 0.57 | 0.85 | MNSTWin |
| TMO has delivered stronger long-term returns, but the risk indicators show mixed results. | |||
MNST vs TMO Valuation & Dividend Metrics
Review MNST compared with TMO across valuation, cash flow and dividend metrics, including P/E, forward P/E, free cash flow yield and dividend yield. These figures are provided for reference only and do not represent a fair-value estimate, price target or investment recommendation.
| Metric | MNST | TMO | Comparison results |
|---|---|---|---|
Market Cap | $42.22B | $249.48B | TMOWin |
P/E (TTM) | 39.7x | 35.8x | TMOWin |
P/S | 9.2x | 5.4x | TMOWin |
EV/EBITDA | 29.3x | 25.4x | TMOWin |
Dividend Yield | 0.00% | 0.27% | TMOWin |
MNST vs TMO Profitability Over Time
Compare MNST and TMO across gross margin and operating margin trends over time to understand how each company's profitability has changed. Based on reported financial data only; not a forecast or investment advice.
| TTM | 3Y Avg | 5Y Avg | 10Y Avg | |
|---|---|---|---|---|
| MNST | 55.8% | 54.3% | 53.9% | 57.6% |
| TMO | 40.9% | 40.7% | 42.9% | 44.4% |
Technical & Fundamental Stock Analysis
RSI (14, daily)
MNST 37.84 • TMO 72.73
Measures short-term price momentum and helps identify possible overbought or oversold conditions.
50/200-DMA Position
MNST 50D Below / 200D Above • TMO 50D Above / 200D Above
Shows whether the stock is trading above or below its medium- and long-term trend lines.
R&D % of Revenue
MNST 0.0% • TMO 3.0%
Shows how much of revenue is invested in research and development.
Share Count Trend (3Y)
MNST Decreased • TMO Decreased
Shows whether the company's share count has increased or decreased over the past three years.
Company Profiles
Monster Beverage Corporation
Soft Drinks & Non-alcoholic Beverages
Monster Beverage is a leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, generating two-thirds of revenue in the US and Canada. The well-known Monster trademark includes brands such as Monster Energy, Monster Ultra, Java Monster, and Juice Monster. The firm also owns other energy drink brands, such as Reign, NOS, Burn, Bang, and Mother, and brews and distributes beers and flavored malt beverages following the acquisition of a craft brewer in 2022. Monster controls branding and innovation but outsources beverage manufacturing and packaging to co-packers and finished goods distribution to bottlers in the global Coca-Cola system (pursuant to a 20-year agreement inked in 2015). Coke is the largest shareholder of Monster, owning a 20% stake.
Thermo Fisher Scientific, Inc.
Life Sciences Tools & Services
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Trade MNST & TMO Stock Futures on MEXC
Trade USDT-margined Stock Futures referencing MNST and TMO on MEXC, with 24/7 access and leverage of up to 10x. These products are derivatives, do not represent ownership of the underlying shares and involve a significant risk of loss.
Everything You Need to Know About MNST vs TMO Stocks
What is MEXC Stock Compare?
MEXC Stock Compare is a side-by-side US stock comparison tool. It helps users compare two companies across stock price performance, market cap, valuation, growth, profitability, balance-sheet strength, dividends and risk. The results are provided for research purposes only and do not constitute investment advice.
Which metrics should I use to evaluate a company's growth?
Start with revenue growth to see how quickly the business is expanding, then review EPS growth to determine whether that growth is translating into higher earnings per share. Gross margin, operating margin and ROIC help assess the quality of that growth by showing profitability and capital efficiency. A company with fast revenue growth but declining margins may be expanding without improving its earnings quality.
How do MNST and TMO compare in growth and profitability?
In the latest reported period, MNST recorded revenue growth of +20.4% and TTM EPS growth of +33.3%, compared with +7.2% and +7.4% for TMO. MNST leads on both growth and profitability. This comparison is based on reported financial metrics and does not predict future performance.
What is the difference between P/E (TTM) and Forward P/E?
P/E (TTM) compares the current share price with actual earnings reported over the past 12 months. Forward P/E uses estimated earnings for the next 12 months, so it reflects market expectations but depends on forecasts that may change. Both ratios should be considered alongside growth, profitability and industry peers.
How do the risk profiles of MNST and TMO compare?
MNST has a 30-day realized volatility of 24.5% and a five-year Beta of 0.57, compared with 24.4% and 0.85 for TMO. The risk indicators show mixed results. These indicators describe historical price movements and market sensitivity, but they do not cover every source of investment risk.
What do dividend yield and payout ratio indicate?
Dividend yield shows the annual dividend relative to the current share price, while the payout ratio shows how much of a company's earnings is distributed as dividends. A higher yield may provide more income, but it can also rise because the share price has fallen. Dividend sustainability should therefore be considered together with earnings, cash flow and the payout ratio.
How should I compare a high-growth stock with a lower-valued stock?
A high-growth stock may trade at a higher valuation if investors expect its revenue and earnings to continue expanding. A lower-valued stock may offer a more conservative entry point, but the lower valuation could also reflect slower growth or higher business risk. Growth, valuation, profitability, cash flow and risk should therefore be considered together.
Which is the better stock, MNST or TMO?
There is no single answer for every investor. Growth-focused investors may place greater weight on revenue growth, EPS growth and ROIC, while income-focused investors may prioritize dividend yield and payout sustainability. Investors with lower risk tolerance may focus more on volatility, Beta and balance-sheet strength. MEXC Stock Compare presents the relevant metrics but does not provide a buy or sell recommendation.
Can I trade MNST and TMO as RealStocks on MEXC?
Eligible users can trade MNST and TMO as real US stocks through MEXC RealStocks if both stocks are currently supported. Users must first open and verify a RealStocks account with MEXC's partner licensed broker. RealStocks represents ownership of actual shares rather than tokenized stock exposure. Availability may vary by stock and region, so users should check the corresponding RealStocks trading page before placing an order.
Disclaimer
The stock prices, financial metrics, comparison results and related information displayed on this page are sourced from third-party providers and are provided for informational and educational purposes only. Data may be delayed, incomplete or inaccurate, and MEXC does not guarantee its accuracy, completeness or timeliness. The comparisons and automated summaries do not constitute financial, investment, legal or tax advice, nor a recommendation to buy, sell or hold any security or financial product. Past performance is not indicative of future results. Users should independently verify the information and assess their own objectives, financial circumstances and risk tolerance before making any decision. Where MEXC stock futures or other derivative products are referenced, such products do not represent ownership of the underlying shares and may involve leverage and a substantial risk of loss. Product availability is subject to applicable laws and regional restrictions.